Good Medicine: Congress Should Pass Market-Based Solutions to Spur Prescription Drug Competition
Mar 13, 2019
The Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act… Read More
© 2024 CSRXP- All Rights Reserved
Updates
CSRxP: Legislative Hearing on Drug Pricing Bills a Positive First Step, Now More Action Needed
Mar 13, 2019
Today, members of the U.S. House Committee on Energy & Commerce… Read More
Second Opinion: Rebate Rule Will Hike Premiums On Seniors
Mar 12, 2019
Lowering prescription drug prices is a laudable focus of the Trump… Read More
Questioning The Rebate Rule
Mar 12, 2019
Secretary Azar Recently Noted The Effectiveness Of PBMs Now Targeted By Agency… Read More
Trump Administration Should Focus on Market-Based Solutions to Alleviate Drug Prices
Mar 11, 2019
As Secretary Azar Heads To Capitol Hill, CSRxP Encourages Lawmakers To… Read More
Headlines: Lawmakers, Patients, Experts Keep-Up Drumbeat For Action On Drug Prices
Mar 9, 2019
Three More Congressional Hearings Tackle Big Pharma’s Anti-Competitive… Read More
ICYMI: House Judiciary Subcommittee on Anti-Trust Members Tout Benefits of CREATES Act
Mar 8, 2019
During today’s House Judiciary Subcommittee on Anti-trust hearing on… Read More
THEY SAID IT! U.S. House Ways & Means Subcommittee Pushes For Increased Competition To Lower Drug Prices
Mar 8, 2019
On Thursday, members of the U.S. House Committee on Ways and Means… Read More
Skyrocketing Drug Prices Place Extreme Financial Burdens On Families
Mar 7, 2019
Patients Tell Congress, Paying For Life-Saving Medications Often Means Going… Read More
THEY SAID IT! Senators On Aging Committee Join Call For Action In Washington To Alleviate Rising Burden Of Prescription Drug Prices
Mar 6, 2019
On Wednesday, five American patients gave eye-opening testimony to members of… Read More
The Truth About Big Pharma’s Patent Abuse
Mar 6, 2019
Big Pharma is able to price gouge patients and avoid accountability. For… Read More
CSRxP Praises Gottlieb For Leadership On Drug Pricing
Mar 6, 2019
FDA Commissioner Was Invaluable Voice In Favor Of Market-Based Solutions To… Read More